Recombinant Human Keratin 19
Cat.No. : | KRT19-616H |
Product Overview : | Recombinant Human Cytokeratin 19 produced inE.Coliis a single, non-glycosylated polypeptide chain having a molecular mass of 44,098 Dalton. The CTK-19 is purified by proprietary chromatographic techniques. |
- Specification
- Gene Information
- Related Products
Cat. No. : | KRT19 -616H |
Description : | CTK-19 is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. |
Source : | E.Coli. |
Physical Appearance : | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation : | The protein (1mg/ml) was lyophilized after from a sterile solution containing 30mM Tris-HCL pH-8, 9.5M urea, 2mM EDTA and 10mM methylammonium chloride. |
Solubility : | It is recommended to reconstitute the lyophilized CTK-19 in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions. |
Stability : | Lyophilized CTK-19 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution CTK-19 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |
Purity : | Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Reconstitution To Filaments : | Performed by mixing equimolar amounts of cytokeratins of type I and type II at concentrations of approx. 0.5 mg/ml, both dissolved in 9.5 M urea buffer (see above). Protofilaments and filament complexes are obtained by dialyzing the resulting polypeptide solution stepwise to a concentration of 4 M urea and then to low salt condition (50 mM NaCI, 2 mM dithiothreitol, 10 mM Tris-HCI, pH 7.4). For immunization purposes, the solution can be further dialyzed against PBS. |
Gene Name : | KRT19 keratin 19 [ Homo sapiens ] |
Synonyms : | keratin 19; K19; CK19; K1CS; MGC15366; keratin, type I cytoskeletal 19; keratin, type I, 40-kd; cytokeratin 19; 40-kDa keratin intermediate filament; CK-19; Cytokeratin-19; Keratin-19; K1C19_HUMAN; KRT19 |
Gene ID : | 3880 |
mRNA Refseq : | NM_002276 |
Protein Refseq : | NP_002267 |
MIM : | 148020 |
UniProt ID : | P08727 |
Chromosome Location : | 17q21.2 |
Pathway : | Cell Communication |
Function : | protein binding; structural constituent of cytoskeleton; structural constituent of muscle |
Products Types
◆ Recombinant Protein | ||
KRT19-2603H | Recombinant Human KRT19 protein(81-390 aa), C-His-tagged | +Inquiry |
KRT19-2972R | Recombinant Rat KRT19 Protein, His (Fc)-Avi-tagged | +Inquiry |
KRT19-0025H | Recombinant Human KRT19 Protein | +Inquiry |
KRT19-2605H | Recombinant Human KRT19 protein(81-400 aa), N-MBP & C-His-tagged | +Inquiry |
KRT19-7239H | Recombinant Human KRT19 Protein, His tagged | +Inquiry |
◆ Native Protein | ||
KRT19-40H | Native Human KRT19 protein | +Inquiry |
KRT19-169H | Native Human Cytokeratin 19 | +Inquiry |
KRT19-5H | Native Human CK19 | +Inquiry |
◆ Lysates | ||
KRT19-4875HCL | Recombinant Human KRT19 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, there are ongoing clinical trials exploring the use of KRT19 as a biomarker and its potential as a therapeutic target in cancer treatment.
Yes, KRT19 can also be used as a biomarker in other diseases, such as liver diseases and rheumatoid arthritis.
Some targeted therapies are being developed that specifically target cancer cells with high KRT19 expression.
Yes, KRT19 expression levels can provide information about the prognosis of cancer patients, helping in treatment planning.
KRT19 protein can be detected using various laboratory techniques, including immunohistochemistry, ELISA, and PCR.
Customer Reviews (3)
Write a reviewSuch support helps researchers overcome challenges and obtain reliable results.
This flexibility allows researchers to focus on specific aspects of KRT19 protein functionality, regulation, or disease associations, enhancing the relevance and applicability of their work.
Manufacturers might offer customization options, such as different variants or modifications of the KRT19 protein, to cater to specific research requirements.
Ask a Question for All KRT19 Products
Required fields are marked with *
My Review for All KRT19 Products
Required fields are marked with *
Inquiry Basket